Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-24 @ 10:37 PM
NCT ID:
NCT07231835
Eligibility Criteria:
Inclusion Criteria:
* Patients undergoing PCI with the Protégé paclitaxel-eluting DCB
* Age ≥ 18 years
* Presence of a de novo lesion or in-stent restenosis in a native coronary artery or a in a bypass graft and suitable for PCI
* Reference vessel diameter between 2.0 - 4.5 mm
* Patient suitable for dual antiplatelet therapy (DAPT)
Exclusion Criteria:
* Inability to provide informed consent
* Allergy to paclitaxel
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07231835
Study Brief:
Protocol Section:
NCT07231835